Back to search

Article

Economic Burden and Clinical Effectiveness of Different Hydroxyurea Dosing Regimens in Sickle Cell Disease: Evidence from Nepal

2025-02-25

Abstract excerpt

Sickel cell disease (SCD) is a genetic potentially debilitating disease with global concern. Hydroxyurea is an oral therapeutic agent with proven laboratory and clinical efficacy for sickle cell anemia. It can be speculated that SCD tends to greatly deplete the finances of households in developing countries where there is high level of poverty and inequitable distribution of wealth and resources. To determine dire...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b97d1e4-426e-519b-a536-1650a7fe786f
DOI
10.20944/preprints202502.1910.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Economic Burden and Clinical Effectiveness of Different Hydroxyurea Dosing Regimens in Sickle Cell Disease: Evidence from NepalDOI 10.20944/preprints202502.1910.v1
Hydroxyurea in the sickle cell disease modern eraSemantic proximity
Optimizing hydroxyurea therapy for sickle cell anemia.Semantic proximity
Updated Worldwide Epidemiology of Inherited Erythrocyte DisordersSemantic proximity
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan AfricaSemantic proximity
Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ(+) thalassemia with IVS1-5(G→C) mutation.Semantic proximity
Sickle cell anaemia therapy in 2025Semantic proximity
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemicSemantic proximity
Drug Therapies for the Management of Sickle Cell DiseaseSemantic proximity
Fixed Low-Dose Hydroxyurea Therapy: A Strategy for Reducing Emergency Room Visits and Improving Treatment Adherence in Paediatric Sickle Cell Anaemia in Resource-Limited SettingsSemantic proximity
Hydroxyurea for Children and Adults with Hemoglobin SC DiseaseSemantic proximity
Hydroxyurea (hydroxycarbamide) for sickle cell disease.Semantic proximity
Barriers to the use of hydroxyurea in the management of sickle cell disease in NigeriaSemantic proximity
Select a neighboring publication to make it the new centre.